Building the future of biometrics innovation - together
The BRAIN Consortium comprises of pharmaceutical biometrics leaders collaborating to implement strategies that accelerates groundbreaking technological advancements.
About the BRAIN Consortium
The BRAIN Consortium is a collaboration between the pharmaceutical and technology industries to innovate technology and data sciences used in the biometrics processes.
Its mission is to spearhead the development, implementation, and uptake of technologies that empower Clinical Data Science, expediting the approval process for groundbreaking medications, ultimately bringing treatments to patients faster.
With BRAIN as the foundational Biometrics and Data Science technology infrastructure, the Consortium focuses on continuing advancements in biometrics through the knowledge graph and AI-automation ecosystem.
What are the benefits to joining the BRAIN Consortium?
- Preview of BRAIN ecosystem developments
- Inputs into consortium initiatives, decision making and priorities
- Participation in round table sessions and speaking slots at events
- Recognition in consortium communications
- Access to shared asset library contributed by members
- Access to innovation created by consortium workstreams
Commercial clients will have exclusive access to influencing the BRAIN roadmap and have access to preferred member discounts.
